Abstract:Structural modification of natural products by biotransformation with fungi is an attractive tool to obtain novel bioactive derivatives. In the present study, cryptotanshinone (1), a quinoid abietane diterpene from traditional Chinese medicine Salvia miltiorrhiza (Danshen), was transformed by two marine-derived fungi. By using Cochliobolus lunatus TA26-46, one new oxygenated and rearranged product (2), containing a 5,6-dihydropyrano[4,3-b]chromene moiety, together with one known metabolite (10), were obtained from the converted broth of cryptotanshinone (1) with the isolated yields of 1.0% and 2.1%, respectively. While, under the action of Aspergillus terreus RA2905, seven new transformation products (3–9) as well as 10 with the fragments of 2-methylpropan-1-ol and oxygenated p-benzoquinone were produced and obtained with the isolated yields of 0.1%–1.3%. The structures of the new compounds were elucidated by comprehensive spectroscopic analysis including High Resolution Electrospray Ionization Mass Spectroscopy (HRESIMS), Nuclear Magnetic Resonance (NMR) and Electronic Circular Dichroism (ECD). The metabolic pathways of cryptotanshinone by these two fungi were presumed to be the opening and rearrangement of furan ring, and/or oxygenation of cyclohexane ring. Cryptotanshinone (1) and its metabolites displayed anti-inflammatory activities against NO production in LPS-stimulated BV-2 cells and antibacterial activities towards methicillin-resistant Staphylococcus aureus. These findings revealed the potential of marine fungi to transform the structures of natural products by biotransformation.

Biotransformation of Three Free Anthraquinones by Mucor Spinosus

Microbial Glycosylation of Four Free Anthraquinones by Absidia Coerulea

In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats

Anthraquinone derivatives from Micromonospora rhodorangea.

Microbial Glycosylation of Cardamonin by Mucor Spinosus.

Biotransformation of Quinoa Phenolic Compounds with Monascus Anka to Enhance the Antioxidant Capacity and Digestive Enzyme Inhibitory Activity

Microbial hydroxylation of cinobufagin by Mucor spinosus.

Biotransformation of 20(S)-protopanaxadiol by Mucor spinosus

Microbial Transformation of Curdione by Mucor Spinosus

Microbial transformation of 20(S)-protopanaxatriol by Mucor spinosus.

Microbial transformation of curcumin by Rhizopus chinensis

Biotransformation of Gastrodin by Mucor spinosus

Annular oxygenation and rearrangement products of cryptotanshinone by biotransformation with marine-derived fungi Cochliobolus lunatus and Aspergillus terreus

Correction To: Anthocyanin Extract from Lycium Ruthenicum Enhanced Production of Biomass and Polysaccharides During Submerged Fermentation of Agaricus Bitorquis (quél.) Sacc. Chaidam

Biotransformation of 20(S)-protopanaxatriol by Mucor spinosus and the cytotoxic structure activity relationships of the transformed products.

[Biotransformation of mogroside III by human intestinal bacteria].

Biotransformation of 20(R)-Panaxadiol by the Fungus Rhizopus Chinensis.

Identification and quantification of target metabolites combined with transcriptome of two rheum species focused on anthraquinone and flavonoids biosynthesis

Generation of xanthohumol derivatives through fungi-mediated biotransformation

Microbial transformation of glycyrrhetinic acid by Mucor polymorphosporus.

Microbial Transformation of 20(<i>S</i>)-Protopanaxatriol by<i>Mucor</i><i>s</i><i>pinosus</i>